Genexine (Korea) Price on December 3, 2024
| 095700 Stock | KRW 5,530 290.00 5.53% |
If you're considering investing in Genexine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genexine stands at 5,530, as last reported on the 11th of December 2024, with the highest price reaching 5,540 and the lowest price hitting 5,190 during the day. Genexine holds Efficiency (Sharpe) Ratio of -0.0181, which attests that the entity had a -0.0181% return per unit of risk over the last 3 months. Genexine exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genexine's Market Risk Adjusted Performance of 0.6342, standard deviation of 5.23, and insignificant Risk Adjusted Performance to validate the risk estimate we provide.
Genexine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genexine |
Sharpe Ratio = -0.0181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 095700 |
Estimated Market Risk
| 5.23 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genexine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genexine by adding Genexine to a well-diversified portfolio.
Genexine Valuation on December 3, 2024
It is possible to determine the worth of Genexine on a given historical date. On December 3, 2024 Genexine was worth 5900.0 at the beginning of the trading date compared to the closed value of 5930.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genexine stock. Still, in general, we apply an absolute valuation method to find Genexine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genexine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genexine's related companies.
| Open | High | Low | Close | Volume | |
| 6,000 | 6,050 | 5,860 | 5,900 | 139,926 | |
12/03/2024 | 5,900 | 6,020 | 5,900 | 5,930 | 110,208 |
| 5,770 | 5,850 | 5,650 | 5,730 | 217,414 |
| Backtest Genexine | | | Genexine History | | | Genexine Valuation | Previous | Next |
Genexine Trading Date Momentum on December 3, 2024
| On December 04 2024 Genexine was traded for 5,730 at the closing time. The highest price during the trading period was 5,850 and the lowest recorded bid was listed for 5,650 . The volume for the day was 217.4 K. This history from December 4, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 3.37% . The overall trading delta to the current price is 12.48% . |
Genexine Fundamentals Correlations and Trends
By evaluating Genexine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genexine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genexine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genexine Stock history
Genexine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genexine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genexine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genexine stock prices may prove useful in developing a viable investing in Genexine
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea. Genexine is traded on Korean Securities Dealers Automated Quotations in South Korea.
Genexine Stock Technical Analysis
Genexine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genexine Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Genexine cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genexine December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Genexine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genexine shares will generate the highest return on investment. By undertsting and applying Genexine stock market strength indicators, traders can identify Genexine entry and exit signals to maximize returns
Genexine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genexine's price direction in advance. Along with the technical and fundamental analysis of Genexine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genexine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.93) | |||
| Treynor Ratio | 0.6242 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Genexine Stock analysis
When running Genexine's price analysis, check to measure Genexine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genexine is operating at the current time. Most of Genexine's value examination focuses on studying past and present price action to predict the probability of Genexine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genexine's price. Additionally, you may evaluate how the addition of Genexine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |